Hussman Strategic Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History

Hussman Strategic Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 01, 2021	SELL	$33.54 - $40.55 $241,488 - $291,960	-7,200 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$42.51 - $63.78 $306,072 - $459,216	7,200 New	7,200 $324,000
Q3 2020 Nov 02, 2020	SELL	$47.45 - $62.95 $1.19 Million - $1.57 Million	-25,000 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$41.6 - $63.4 $1.04 Million - $1.59 Million	25,000 New	25,000 $1.18 Million

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.